scPharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary

Scpharmaceuticals

13/03/2024 21:01

* scPharmaceuticals Inc  SCPH.OQ  reported a quarterly
adjusted
loss of 35 cents​​ per share for the quarter ended in December,
lower than the same quarter last year, when the company reported
EPS of -30 cents.  The mean expectation of six analysts for the
quarter was for a loss of 42 cents per share. Wall Street
expected results to range from -52 cents to -32 cents per share.
    * Revenue was $6.10 million​; analysts expected $5.53
million. 
    * scPharmaceuticals Inc's reported EPS for the quarter was a
loss
of 35 cents​.
    * The company reported a quarterly loss of $13.81 million.
    * scPharmaceuticals Inc shares had fallen by 14.5% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts had risen by
about 0.4%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for scPharmaceuticals
Inc is $18.00 
This summary was machine generated from LSEG data March 13 at
09:00 p.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.42          -0.35          Beat
 Sep. 30 2023      -0.36          -0.41          Missed
 Jun. 30 2023      -0.37          -0.36          Beat
 Mar. 31 2023      -0.36          -0.30          Beat